Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,474,000 | 2,670,100 | 3,695,700 | 3,593,200 | 2,941,600 |
| Depreciation Amortization | 650,500 | 1,081,000 | 682,700 | 600,400 | 688,100 |
| Income taxes - deferred | 108,300 | 91,700 | -175,000 | -145,600 | -308,200 |
| Accounts receivable | -205,200 | -435,600 | -241,400 | 29,000 | -512,400 |
| Other Working Capital | 400,200 | 235,400 | 125,200 | -450,400 | -484,400 |
| Other Operating Activity | 759,900 | 908,400 | 500,000 | 292,800 | 617,400 |
| Operating Cash Flow | $6,187,700 | $4,551,000 | $4,587,200 | $3,919,400 | $2,942,100 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -770,600 | -867,400 | -616,100 | -643,000 | -287,800 |
| Net Acquisitions | -1,962,900 | -1,200,000 | -1,200,000 | -1,048,800 | -375,000 |
| Purchase Of Investment | -8,371,399 | -5,355,200 | -7,913,200 | -6,864,900 | -3,583,100 |
| Sale Of Investment | 9,173,700 | 5,565,900 | 7,378,900 | 4,063,000 | 2,718,900 |
| Purchase Sale Intangibles | -115,500 | -1,095,400 | -111,600 | -15,400 | -28,200 |
| Other Investing Activity | -115,101 | -1,106,400 | -134,400 | -59,900 | -16,000 |
| Investing Cash Flow | $-2,046,300 | $-2,963,100 | $-2,484,800 | $-4,553,600 | $-1,543,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 0 | N/A | N/A | 5,930,500 | 0 |
| Debt Repayment | -3,200 | -560,900 | -2,700 | -2,100 | -2,700 |
| Common Stock Issued | 0 | N/A | -8,500 | -70,900 | 54,900 |
| Common Stock Repurchased | -4,352,600 | -1,365,400 | -1,000,000 | -5,000,000 | -886,800 |
| Other Financing Activity | -116,200 | -453,700 | -41,400 | -74,400 | 78,700 |
| Financing Cash Flow | $-4,472,000 | $-2,380,000 | $-1,052,600 | $783,100 | $-755,900 |
| Exchange Rate Effect | -18,600 | 39,400 | -31,300 | -45,800 | -40,900 |
| Beginning Cash Position | 1,573,800 | 2,326,500 | 1,308,000 | 1,204,900 | 602,600 |
| End Cash Position | 1,224,600 | 1,573,800 | 2,326,500 | 1,308,000 | 1,204,900 |
| Net Cash Flow | $-349,200 | $-752,700 | $1,018,500 | $103,100 | $602,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | 6,187,700 | 4,551,000 | 4,587,200 | 3,919,400 | 2,942,100 |
| Capital Expenditure | -770,600 | -867,400 | -616,100 | -643,000 | -287,800 |
| Free Cash Flow | 5,417,100 | 3,683,600 | 3,971,100 | 3,276,400 | 2,654,300 |